Charles River Laboratories International (CRL) Long-Term Debt Issuances (2016 - 2025)
Historic Long-Term Debt Issuances for Charles River Laboratories International (CRL) over the last 16 years, with Q3 2025 value amounting to $107.5 million.
- Charles River Laboratories International's Long-Term Debt Issuances fell 5436.94% to $107.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year decrease of 1721.31%. This contributed to the annual value of $1.1 billion for FY2024, which is 3931.56% up from last year.
- According to the latest figures from Q3 2025, Charles River Laboratories International's Long-Term Debt Issuances is $107.5 million, which was down 5436.94% from $547.0 million recorded in Q2 2025.
- In the past 5 years, Charles River Laboratories International's Long-Term Debt Issuances registered a high of $3.0 billion during Q2 2021, and its lowest value of $51.2 million during Q3 2023.
- In the last 5 years, Charles River Laboratories International's Long-Term Debt Issuances had a median value of $440.3 million in 2024 and averaged $675.4 million.
- As far as peak fluctuations go, Charles River Laboratories International's Long-Term Debt Issuances skyrocketed by 11197280000.0% in 2021, and later crashed by 9267.17% in 2023.
- Charles River Laboratories International's Long-Term Debt Issuances (Quarter) stood at $831.4 million in 2021, then tumbled by 81.51% to $153.8 million in 2022, then skyrocketed by 188.31% to $443.3 million in 2023, then tumbled by 76.36% to $104.8 million in 2024, then rose by 2.58% to $107.5 million in 2025.
- Its last three reported values are $107.5 million in Q3 2025, $547.0 million for Q2 2025, and $416.3 million during Q1 2025.